Cleared Traditional

K230273 - Saranas Early Bird Bleed Monitoring System (FDA 510(k) Clearance)

May 2023
Decision
114d
Days
Class 2
Risk

K230273 is an FDA 510(k) clearance for the Saranas Early Bird Bleed Monitoring System. This device is classified as a Intravascular Bleed Monitor (Class II - Special Controls, product code QFJ).

Submitted by Saranas, Inc. (Houston, US). The FDA issued a Cleared decision on May 25, 2023, 114 days after receiving the submission on January 31, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1345. An Intravascular Bleed Monitor Is A Probe, Catheter, Or Catheter Introducer That Measures Changes In Bioimpedance And Uses An Algorithm To Detect Or Monitor Progression Of Potential Internal Bleeding Complications..

Submission Details

510(k) Number K230273 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2023
Decision Date May 25, 2023
Days to Decision 114 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QFJ - Intravascular Bleed Monitor
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1345
Definition An Intravascular Bleed Monitor Is A Probe, Catheter, Or Catheter Introducer That Measures Changes In Bioimpedance And Uses An Algorithm To Detect Or Monitor Progression Of Potential Internal Bleeding Complications.